Changing views of the role of matrix metalloproteinases in metastasis
- PMID: 9293916
- DOI: 10.1093/jnci/89.17.1260
Changing views of the role of matrix metalloproteinases in metastasis
Abstract
Metastatic spread of cancer continues to be the greatest barrier to cancer cure. Understanding the molecular mechanisms of metastasis is crucial for the design and effective use of novel therapeutic strategies to combat metastases. One class of molecules that has been repeatedly implicated in metastasis is the matrix metalloproteinases (MMPs). In this review, we re-examine the evidence that MMPs are associated with metastasis and that they make a functional contribution to the process. Initially, it was believed that the major role of MMPs in metastasis was to facilitate the breakdown of physical barriers to metastasis, thus promoting invasion and entry into and out of blood or lymphatic vessels (intravasation, extravasation). However, recent evidence suggests that MMPs may have a more complex role in metastasis and that they may make important contributions at other steps in the metastatic process. Studies using intravital videomicroscopy, as well as experiments in which levels of MMPs or their inhibitors (tissue inhibitors of metalloproteinases [TIMPs]) are manipulated genetically or pharmacologically, suggest that MMPs are key regulators of growth of tumors, at both primary and metastatic sites. On the basis of this evidence, a new view of the functional role of MMPs in metastasis is presented, which suggests that MMPs are important in creating and maintaining an environment that supports the initiation and maintenance of growth of primary and metastatic tumors. Further clarification of the mechanisms by which MMPs regulate growth of primary and metastatic tumors will be important in the development of novel therapeutic strategies against metastases.
Similar articles
-
Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitors.Cytotechnology. 1993;12(1-3):367-84. doi: 10.1007/BF00744674. Cytotechnology. 1993. PMID: 7764458 Review.
-
Matrix metalloproteinases in cancer metastasis: molecular _targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins.Endocr Metab Immune Disord Drug _targets. 2006 Mar;6(1):17-24. doi: 10.2174/187153006776056648. Endocr Metab Immune Disord Drug _targets. 2006. PMID: 16611161 Review.
-
Matrix metalloproteinases in tumor invasion and metastasis.Semin Cancer Biol. 2000 Dec;10(6):415-33. doi: 10.1006/scbi.2000.0379. Semin Cancer Biol. 2000. PMID: 11170864 Review.
-
Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.Crit Rev Eukaryot Gene Expr. 1997;7(1-2):159-78. doi: 10.1615/critreveukargeneexpr.v7.i1-2.90. Crit Rev Eukaryot Gene Expr. 1997. PMID: 9034720 Review.
-
Complex roles of tissue inhibitors of metalloproteinases in cancer.Oncogene. 2002 Mar 28;21(14):2245-52. doi: 10.1038/sj.onc.1205291. Oncogene. 2002. PMID: 11948407 Review.
Cited by
-
Proteostasis and Its Role in Disease Development.Cell Biochem Biophys. 2024 Oct 18. doi: 10.1007/s12013-024-01581-6. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39422790
-
Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.PLoS One. 2024 Sep 27;19(9):e0308947. doi: 10.1371/journal.pone.0308947. eCollection 2024. PLoS One. 2024. PMID: 39331595 Free PMC article.
-
The role of Rhizoma Paridis saponins on anti-cancer: The potential mechanism and molecular _targets.Heliyon. 2024 Sep 2;10(17):e37323. doi: 10.1016/j.heliyon.2024.e37323. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39296108 Free PMC article. Review.
-
Role of NOX1 and NOX5 in protein kinase C/reactive oxygen species‑mediated MMP‑9 activation and invasion in MCF‑7 breast cancer cells.Mol Med Rep. 2024 Oct;30(4):188. doi: 10.3892/mmr.2024.13312. Epub 2024 Sep 2. Mol Med Rep. 2024. PMID: 39219290 Free PMC article.
-
System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis.Front Pharmacol. 2024 May 22;15:1364138. doi: 10.3389/fphar.2024.1364138. eCollection 2024. Front Pharmacol. 2024. PMID: 38841373 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources